Drugs / 122-0551
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01700985 | May → Sep 2012 | psoriasis | Therapeutics, Inc. | Completed | Met primary |
| Phase 2 | NCT01698333 | Apr 2012 → Mar 2013 | psoriasis | Therapeutics, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 122-0551 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01698333 ↗ |
| Route | Topical | “Applied twice daily for two weeks” NCT01700985 ↗ |